Federación Española de Diabetes (FEDE)

What Federación Española de Diabetes (FEDE) does

Federación Española de Diabetes (FEDE), legally FEDERACIÓN ESPAÑOLA DE DIABETES, is a Spanish non-profit patient advocacy federation founded in 1986 and headquartered in Fuenlabrada, Madrid, that serves as the national umbrella organization uniting 18 regional federations and autonomous associations of people with diabetes across Spain. It operates a community-led model reaching people with diabetes (all types), children/adolescents, families, caregivers, schools, and healthcare professionals through member associations, national events, digital educational platforms, and policy advocacy, with a small central staff of approximately 11 employees.

FEDE's product portfolio is centered on diabetes education, awareness, and community rather than proprietary software. Core offerings include the Agente Educativo en Diabetes online therapeutic education course (10 modules covering glucose management, nutrition, insulin adjustment, physical activity, psychosocial aspects, and innovation) delivered through the Campus FEDE learning management system; the bimonthly Revista DiabetesFEDE magazine; the FEDE Conecta podcast; the Programa KiDS school-based diabetes education program co-developed with IDF and ISPAD (reaching 1,600+ students in 66 schools); the Campamentos FEDE national summer camps (first edition June 2025 in Toledo for ages 15-18); the Haciendo Camino walking program along the Camino de Santiago (co-led with Fundación para la Salud de Novo Nordisk España); the X Congreso Nacional FEDE and V Congreso Juventud y Diabetes congresses; and campaigns including Inmunización, Crecer Sin Diabetes, and Síndrome metabólico. Underlying technology is modest: a Moodle-based LMS, a content website, podcast hosting on third-party platforms, and social media accounts on X and TikTok.

The business model is a hybrid non-profit revenue structure. Primary revenue streams are membership dues from the 18 federaciones and asociaciones miembro, plus project-based collaborations with pharmaceutical and healthcare industry partners (Abbott, Boehringer Ingelheim, Dexcom, MSD, Novo Nordisk, Sanofi, Lilly, Bayer, Almirall, Menarini, Farmaindustria, Sandoz, Biosim, GSK, Abbvie, etc.) that fund specific educational programs, camps, awards, and campaigns. Program-level pricing is modest and per-event: €200 for the national camp, €20/€320 for Haciendo Camino, €50 for Jornadas Diabetes y Bienestar, and €4,000 total for the KiDS grants distributed across up to 10 entities. Go-to-market is community-led through the federation network rather than direct B2B/B2C sales.

Name

Federación Española de Diabetes (FEDE)

Legal name

FEDERACIÓN ESPAÑOLA DE DIABETES

Website

https://fedesp.es

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Federación Española de Diabetes (FEDE) is a Spanish non-profit patient advocacy federation uniting 18 regional diabetes associations to deliver diabetes education, community programs, and health-policy advocacy for people with diabetes across Spain.

Ownership category

akta.pro rank

Product category

Patient Advocacy and Diabetes Education Services

NAICS

Voluntary Health Organizations (813212), Religious, Grantmaking, Civic, Professional, and Similar Organizations (813)

SIC

Services-Membership Organizations (8600), Services-Educational Services (8200)

akta.pro primary industry

Nutrition & Food Security (Global Health) NGOs (HLAJAKAH)

Keywords

• Diabetes patient advocacy
• Diabetes education programs
• Patient association federation
• Diabetes community support
• Nonprofit health federation

Headquarters

HQ city

Fuenlabrada, Madrid

HQ country

Spain

HQ region

Europe

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Membership dues: FEDE is a federation of regional and local diabetes associations (federaciones and asociaciones miembro). Revenues are derived from membership fees and public/private project funding from pharmaceutical companies that support its educational programs and campaigns.
2. Pharmaceutical and healthcare industry project partnerships: FEDE receives support from pharmaceutical companies (Abbott, Boehringer Ingelheim, Dexcom, MSD, Novo Nordisk, Sanofi, Lilly, Bayer, Almirall, Menarini, Farmaindustria, etc.) for campaigns, educational programs, camps, awards, and research initiatives. These are structured as project-based collaborations rather than equity or investment relationships.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels11 records

Core offering

Federación Española de Diabetes (FEDE) is the national federation of diabetes patient associations in Spain, delivering diabetes therapeutic education, awareness campaigns, advocacy, and community programs to people with diabetes and their families. Its portfolio includes the DiabetesFEDE bimonthly magazine and FEDE Conecta podcast for information dissemination, the Agente Educativo en Diabetes online course and Programa KiDS school program for therapeutic education, national and youth congresses plus summer camps for community building, and the Haciendo Camino pilgrimage program for physical activity and education. The federation operates through 18 member associations across Spain's autonomous communities.

Product overview

Federación Española de Diabetes (FEDE) is a national patient advocacy federation representing autonomous diabetes federations and associations across Spain. FEDE does not offer a software product platform; its portfolio consists of educational, informational, and community programs. Core offerings include the bimonthly Revista DiabetesFEDE magazine and the FEDE Conecta podcast for information dissemination; the Agente Educativo en Diabetes online course and Programa KiDS school program for therapeutic education; Campamentos FEDE, the V Congreso Juventud y Diabetes, and the annual National Congress for community and professional events; and Haciendo Camino and the Diabetes y Bienestar jornadas for wellness-oriented programs. All programs are designed to improve diabetes education, patient empowerment, and quality of life for people living with diabetes in Spain.

Differentiator

Problem solved

Functional benefit

Products and services

• Revista DiabetesFEDE

Quantifiable outcome

• Programa KiDS reached 1,600+ students in 66 schools
• +3 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

42 partnerships are on record, tiered core and minor.

• AbbottcoreGTM or Marketing PartnerAbbott supports FEDE's 'Agente Educativo en Diabetes' program and the third edition of the 'Guía Quién es Quién' publication, helping to fund diabetes education and association visibility.
• Boehringer IngelheimcoreGTM or Marketing PartnerBoehringer Ingelheim supports the 'Agente Educativo en Diabetes' program as part of FEDE's educational diabetes initiative.
• DexcomcoreGTM or Marketing PartnerDexcom supports the 'Agente Educativo en Diabetes' program, contributing to diabetes education efforts.
• MSDcoreGTM or Marketing PartnerMSD supports the 'Agente Educativo en Diabetes' program as part of the multi-company educational initiative.
• Novo NordiskcoreGTM or Marketing PartnerNovo Nordisk supports the 'Agente Educativo en Diabetes' program and the 'Haciendo Camino' project along the Camino de Santiago.
• SanoficoreGTM or Marketing PartnerSanofi supports multiple FEDE programs including 'Becas Diguan' for diabetes camps, the 'Programa KiDS' for school-based education, FEDE national camps, and the 'Inmunización' vaccination campaign. Sanofi also supported the 2024 and 2025 Programa KiDS grant programs.
• Lilly EspañaminorGTM or Marketing PartnerLilly España supports the FEDE National Summer Camp for youth with diabetes as a collaborating sponsor.
• GullónminorGTM or Marketing PartnerGullón supports the FEDE National Summer Camp for youth with diabetes as a collaborating sponsor.
• MedtronicminorGTM or Marketing PartnerMedtronic supports the 'Haciendo Camino' project, providing new technology education sessions during the Camino de Santiago walk.
• Fondation AuchancoreGTM or Marketing PartnerFondation Auchan supports FEDE's diabetes camp grants and the 'Haciendo Camino' project, contributing to nutrition education and physical activity programs.
• Fundación para la Salud de Novo Nordisk España (FSNN)coreStrategic or Co-development PartnerFSNN co-leads the 'Haciendo Camino' project with FEDE, enabling people with diabetes to walk the Camino de Santiago while receiving diabetes education and healthcare support.
• RenfeminorGTM or Marketing PartnerRenfe supports the 'Haciendo Camino 2024' project as a collaborating partner.
• InordeminorGTM or Marketing PartnerInorde (Instituto Ourensán de Desarrollo Económico) collaborated on the 'Haciendo Camino 2024' project in the province of Ourense.
• AbbottminorGTM or Marketing PartnerAbbott supports 'Haciendo Camino 2025' as a collaborating partner.
• Pic SolutionminorGTM or Marketing PartnerPic Solution supports 'Haciendo Camino 2025' as a collaborating partner.
• AlmirallminorGTM or Marketing PartnerAlmirall supports the 'Síndrome metabólico' campaign launched by FEDE under the slogan 'Tu diabetes bajo control'.
• A. Menarini DiagnosticsminorGTM or Marketing PartnerA. Menarini Diagnostics supported a FEDE survey on glucose monitoring systems usage and user satisfaction in Spain.
• BidafarmaminorGTM or Marketing PartnerBidafarma collaborated with FEDE on the survey 'El valor añadido del papel del farmacéutico' regarding diabetes management.
• FarmaindustriacoreStrategic or Co-development PartnerFEDE and Farmaindustria signed a collaboration agreement to promote prevention, research, and treatment adherence for people with diabetes, including joint reports, training activities, and biomedical research education.
• Sociedad Española de Periodoncia (SEPA)minorStrategic or Co-development PartnerSEPA collaborated with FEDE and SED to present a scientific report calling for expanded public dental coverage for people with diabetes.
• Sociedad Española de Diabetes (SED)minorStrategic or Co-development PartnerSED collaborated with FEDE and SEPA on the report demanding expanded public dental coverage for people with diabetes.
• CIBERDEMcoreStrategic or Co-development PartnerCIBERDEM (Biomedical Research Networking Centre on Diabetes and Associated Metabolic Diseases) collaborates with FEDE on research initiatives including the Patient Engagement session at the CIBERDEM & CIBEREHD Scientific Joint Day.
• CIBEREHDminorStrategic or Co-development PartnerCIBEREHD co-organized the scientific joint day with CIBERDEM where FEDE participated in a patient engagement session.
• ALCER (Federación Nacional de Asociaciones para la Lucha Contra las Enfermedades del Riñón)minorStrategic or Co-development PartnerALCER leads the 'Actúa por tus riñones' screening campaign. FEDE provides scientific endorsement (aval) for the initiative addressing chronic kidney disease, a major complication of diabetes.
• Boehringer IngelheimminorGTM or Marketing PartnerBoehringer Ingelheim financially supports the 'Actúa por tus riñones' screening campaign organized by ALCER, with scientific endorsement from FEDE.
• CardioalianzaminorGTM or Marketing PartnerCardioalianza provides scientific endorsement alongside FEDE for the 'Actúa por tus riñones' chronic kidney disease screening campaign.
• BayerminorGTM or Marketing PartnerBayer collaborated with FEDE on the 'Claves de la enfermedad renal crónica y diabetes' jornada in Valencia, addressing early diagnosis of chronic kidney disease in people with diabetes.
• Plataforma de Organizaciones de Pacientes (POP)coreStrategic or Co-development PartnerFEDE participates in the POP's European Breakfasts (Desayunos POP Políticos) and collaborates on patient representation in Spanish and European health policy.
• Alianza por la ObesidadminorStrategic or Co-development PartnerFEDE participates in the 'Alianza por la Obesidad' alongside other patient associations and scientific societies to advocate for comprehensive obesity care in Spain.
• GSKminorGTM or Marketing PartnerGSK provided scientific endorsement for the 'Inmunización 2024' vaccination campaign organized by FEDE.
• MSDminorGTM or Marketing PartnerMSD provided scientific endorsement for the 'Inmunización 2024' vaccination campaign organized by FEDE.
• SanofiminorGTM or Marketing PartnerSanofi provided scientific endorsement for the 'Inmunización 2024' vaccination campaign organized by FEDE.
• Asociación Española de Vacunología (AEV)minorStrategic or Co-development PartnerAEV provides scientific endorsement for FEDE's 'Inmunización' vaccination campaign and collaborated on the webinar 'Vacunación en diabetes'.
• Federación Internacional de Diabetes (IDF)coreStrategic or Co-development PartnerIDF co-developed the Programa KiDS (Kids and Diabetes in Schools) together with ISPAD. FEDE coordinates the program in Spain.
• Sociedad Internacional para la Diabetes Pediátrica y Adolescente (ISPAD)coreStrategic or Co-development PartnerISPAD co-developed the Programa KiDS materials together with IDF. FEDE coordinates the program in Spain.
• Ministerio de Derechos Sociales, Consumo y Agenda 2030coreGTM or Marketing PartnerThe Ministry of Social Rights, Consumption and Agenda 2030 supports the 'Agente Educativo en Diabetes' program as a collaborating partner.
• SandozminorGTM or Marketing PartnerSandoz supports the 'Agente Educativo en Diabetes' program as a collaborating sponsor.
• BiosimminorGTM or Marketing PartnerBiosim supports the 'Agente Educativo en Diabetes' program as a collaborating sponsor.
• GSKminorGTM or Marketing PartnerGSK supports the 'Agente Educativo en Diabetes' program as a collaborating sponsor.
• AbbvieminorGTM or Marketing PartnerAbbvie supports the 'Agente Educativo en Diabetes' program as a collaborating sponsor.
• Fundación de la Sociedad Española de Diabetes (SED)coreStrategic or Co-development PartnerThe Fundación SED, together with FEDE, organized the 2025 World Diabetes Day event and collaborates on diabetes awareness and advocacy initiatives.
• Ailin HealthminorGTM or Marketing PartnerAilin Health financially supports the 'Actúa por tus riñones' chronic kidney disease screening campaign.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Plataforma de Organizaciones de Pacientes (POP): Spanish umbrella of patient organizations across diseases. FEDE is a member; directly comparable as a federation advocating patient participation in Spanish and European health policy (Desayunos POP).
• JDRF International (Breakthrough T1D): Global Type 1 diabetes research and advocacy organization. Direct peer in mission (T1D patient advocacy, school programs, research engagement) and a potential competitor for international pharma grants and KiDS-style programs.
• International Diabetes Federation (IDF): Global umbrella of national diabetes associations of which FEDE is a member. Directly comparable as a federation of patient associations working on diabetes policy, education, and the KiDS program (which FEDE co-develops in Spain).
• Sociedad Española de Diabetes (SED): Spanish scientific society of diabetes professionals. Direct peer in the Spanish diabetes ecosystem, co-publishing scientific reports and co-organizing events with FEDE, but focused on clinicians rather than patients.
• ALCER (Federación Nacional de Asociaciones para la Lucha Contra las Enfermedades del Riñón): Spanish national federation for kidney disease associations. Direct peer in operating model (regional associations, national coordination, pharma-funded campaigns) and a current co-partner with FEDE on the 'Actúa por tus riñones' screening campaign.
• Alianza por la Obesidad: Spanish multi-stakeholder alliance focused on obesity advocacy. FEDE is a member; directly comparable as an adjacent Spanish patient-policy coalition that shares pharma sponsors and policy advocacy channels with FEDE.

Broad incumbents

• Diabetes UK: UK national diabetes charity offering education, campaigns, and research funding. Closest analog to FEDE by mission and federated structure, providing a useful benchmark for European national-federation scale.
• American Diabetes Association: Largest US diabetes patient advocacy organization. Comparable to FEDE as a national federation delivering diabetes education, advocacy, and research funding, but at a much larger scale and with broader fundraising infrastructure.

Regional players

• Diabetes Australia: Australian national diabetes federation. Comparable in mission and federated structure (state-based member organizations), but operates in a different geography; useful peer for international scale benchmarking.
• Federación Española de Enfermedades Raras (FEDER): Spanish national federation for rare disease patient associations. Highly comparable in operating model (umbrella of regional associations, awareness campaigns, member services) but focused on rare diseases rather than diabetes.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/FEDE_Diabetes
• TikToktiktok.com/@diabetes_fede
• LinkedInlinkedin.com/company/federacion-espanola-diabetes-fede

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Federación Española de Diabetes (FEDE)